Docebo Inc. (DCBO) stock
Close on Nov 17, 2026Market cap $834.82MP/E 22.7Yield –
Earnings
Docebo's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Docebo's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 7, 2026before the open | $68.65M | +13.0% | $0.08 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 21, 2026before the open | – | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 29, 2026before the open | – | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 8, 2025before the open | $60.73M | – | $0.10 | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 9, 2025before the open | $57.30M | +11.5% | $0.05 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 28, 2025before the open | $57.00M | +15.6% | $0.38 | $0.28 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 8, 2024before the open | $55.43M | +19.2% | $0.16 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 10, 2024during market hours | $51.40M | – | $0.17 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 23, 2024before the open | $49.30M | – | $0.10 | $0.25 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 9, 2023before the open | $46.51M | – | $0.12 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023before the open | $43.59M | – | -$0.17 | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023before the open | – | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 9, 2023before the open | – | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022before the open | – | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 11, 2022before the open | – | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022before the open | – | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 10, 2022before the open | – | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 12, 2021before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Docebo's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Total RevenueGAAP | FY2026 | $271.00M – $273.00M | $267.50M – $269.50M | Raised | Apr 21, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $54.50M – $56.50M | $52.50M – $54.50M | Raised | Apr 21, 2026 |
| Subscription RevenueGAAP | FY2026 | $253.50M – $255.50M | – | New | Apr 21, 2026 |
Guidance vs results
The last range Docebo gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q1 FY2025 | Revenue | $57.00M – $57.20M | $57.30M | Above range |
| Q1 FY2024 | Revenue | $51.00M – $51.30M | $51.40M | Above range |
Guidance history
Every forecast Docebo put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Apr 21, 2026 | Adjusted EBITDA | FY2026 | $54.50M – $56.50M | Raised |
| Apr 21, 2026 | Subscription Revenue | FY2026 | $253.50M – $255.50M | New |
| Apr 21, 2026 | Total Revenue | FY2026 | $271.00M – $273.00M | Raised |
| Jan 29, 2026 | Adjusted EBITDA | FY2026 | $52.50M – $54.50M | New |
| Jan 29, 2026 | Total revenue | FY2026 | $267.50M – $269.50M | New |
| Feb 28, 2025 | Adjusted EBITDA as a percentage of total revenue | Q1 FY2025 | 14.5% – 15% | New |
| Feb 28, 2025 | Adjusted EBITDA as a percentage of total revenue | FY2025 | 18% – 19% | New |
| Feb 28, 2025 | Subscription revenue growth | FY2025 | +11.5% – +12.5% | New |
| Feb 28, 2025 | Subscription revenue growth | FY2025 | +13% – +14% | New |
| Feb 28, 2025 | Total revenue | Q1 FY2025 | $57.00M – $57.20M | New |
| Feb 28, 2025 | Total revenue growth | FY2025 | +11% – +12% | New |
| Feb 28, 2025 | Total revenue growth | FY2025 | +12.5% – +13.5% | New |
| Feb 23, 2024 | Adjusted EBITDA as a percentage of total revenue | Q1 FY2024 | 12.5% – 13.5% | New |
| Feb 23, 2024 | Gross profit margin | Q1 FY2024 | 81% – 81.5% | New |
| Feb 23, 2024 | Total revenue | Q1 FY2024 | $51.00M – $51.30M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Docebo filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?